The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis
- PMID: 20603707
- PMCID: PMC3073049
- DOI: 10.1007/s00198-010-1338-7
The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis
Abstract
Summary: Osteoporosis is a well recognized complication of ankylosing spondylitis (AS). This study indicates that increased bone turnover, inflammation, and low vitamin D levels are important in the pathophysiology of AS-related osteoporosis, and that bone turnover markers (BTM) are valuable markers to detect bone loss in AS.
Introduction: The aim of this study was to elucidate the pathophysiology of AS-related osteoporosis by investigating the relation between bone mineral density (BMD), BTM, vitamin D, and clinical assessments of disease activity and physical function, as well as to identify parameters that are related to low BMD (osteopenia or osteoporosis) in AS patients with active disease.
Methods: One hundred twenty-eight consecutive Dutch AS outpatients were included in this cross-sectional study. Bath AS Disease Activity Index (BASDAI), erythrocyte sedimentation rate (ESR), C-reactive protein, ASAS-endorsed disease activity score (ASDAS), Bath AS Functional Index (BASFI), bone formation markers procollagen type 1 N-terminal peptide (PINP) and osteocalcin (OC), bone resorption marker serum C-telopeptides of type I collagen (sCTX), 25-hydroxyvitamin D (25OHvitD), lumbar spine and hip BMD, and vertebral fractures were assessed. Z-scores of BTM were calculated using matched 10-year cohorts of a Dutch reference group to correct for the normal influence that age and gender have on bone turnover.
Results: sCTX Z-score, OC Z-score, BASDAI, age, and gender were independently related to low BMD. In addition, PINP Z-score, ESR, 25OHvitD, age, and gender were independently related to sCTX and/or OC Z-score.
Conclusions: This study indicates that increased bone turnover, inflammation, and low vitamin D levels are important in the pathophysiology of AS-related osteoporosis. Furthermore, sCTX and OC Z-scores seem to be valuable markers to detect bone loss in AS patients in daily clinical practice where BMD of the lumbar spine, measured by DXA, may be overestimated due to osteoproliferation in patients with advanced AS.
Figures

Similar articles
-
Higher bone turnover is related to spinal radiographic damage and low bone mineral density in ankylosing spondylitis patients with active disease: a cross-sectional analysis.PLoS One. 2014 Jun 11;9(6):e99685. doi: 10.1371/journal.pone.0099685. eCollection 2014. PLoS One. 2014. PMID: 24918782 Free PMC article.
-
The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis.Rheumatol Int. 2010 Jan;30(3):375-81. doi: 10.1007/s00296-009-0975-7. Epub 2009 Aug 14. Rheumatol Int. 2010. PMID: 19685057
-
Relationship of bone mineral density with disease activity and functional ability in patients with ankylosing spondylitis: a cross-sectional study.Rheumatol Int. 2012 Sep;32(9):2801-8. doi: 10.1007/s00296-011-2066-9. Epub 2011 Aug 20. Rheumatol Int. 2012. PMID: 21858541
-
Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis.Osteoporos Int. 2024 Jan;35(1):25-40. doi: 10.1007/s00198-023-06925-1. Epub 2023 Oct 9. Osteoporos Int. 2024. PMID: 37814094
-
Clinical studies on bone-related outcome and the effect of TNF-α blocking therapy in ankylosing spondylitis.Curr Opin Rheumatol. 2014 May;26(3):259-68. doi: 10.1097/BOR.0000000000000053. Curr Opin Rheumatol. 2014. PMID: 24625371 Review.
Cited by
-
Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis.Br J Clin Pharmacol. 2021 Feb;87(2):644-651. doi: 10.1111/bcp.14431. Epub 2020 Jul 5. Br J Clin Pharmacol. 2021. PMID: 32530102 Free PMC article.
-
Ankylosing spondylitis confers substantially increased risk of clinical spine fractures: a nationwide case-control study.Osteoporos Int. 2015 Jan;26(1):85-91. doi: 10.1007/s00198-014-2939-3. Epub 2014 Oct 24. Osteoporos Int. 2015. PMID: 25341971
-
Surgical arthritis service weekly rounds: ankylosing spondylitis.HSS J. 2011 Jul;7(2):194-205. doi: 10.1007/s11420-011-9210-7. Epub 2011 Jun 25. HSS J. 2011. PMID: 22754423 Free PMC article. No abstract available.
-
The vitamin D status in ankylosing spondylitis in relation to intestinal inflammation, disease activity, and bone health: a cross-sectional study.Osteoporos Int. 2016 Jun;27(6):2027-33. doi: 10.1007/s00198-016-3489-7. Epub 2016 Jan 25. Osteoporos Int. 2016. PMID: 26809190
-
Levels of osteocalcin and N-terminal telopeptide of type I collagen in men with ankylosing spondylitis: associations with disease course and structural-functional status of bone tissue.Reumatologia. 2025 Jun 20;63(3):144-151. doi: 10.5114/reum/201175. eCollection 2025. Reumatologia. 2025. PMID: 40678026 Free PMC article.
References
-
- Cooper C, Carbone L, Michet CJ, et al. Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol. 1994;21(10):1877–1882. - PubMed
-
- Franck H, Meurer T, Hofbauer LC. Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis. J Rheumatol. 2004;31(11):2236–2241. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous